You May Write A Minimum 2-Page, 12-Font, Double-Spaced Resea ✓ Solved

You May Write A Minimum 2 Page 12 Font Double Spaced Research Paper

Write a minimum 2-page (12 font, double-spaced) research paper on a medical condition. The paper should include a brief history (1 paragraph) on the discovery of the condition, a discussion of diagnosis (including subjective symptoms, objective signs, laboratory and physical exam diagnostic tools and findings), treatment options, and prognosis for people living with the condition. Citations are required and do not count toward the 2-page minimum. Use credible sources such as research articles from PubMed.gov, The Mayo Clinic, or the Merck Manual. Wikipedia and WebMD are not acceptable scholarly sources. Ensure proper spelling, grammar, and punctuation, and have someone proofread your work before submission. Use credible websites with .edu, .gov, or reputable .org domains when sourcing information. Avoid .com websites, which are often commercial.

Sample Paper For Above instruction

Introduction

My chosen medical condition for this research paper is Type 2 Diabetes Mellitus, a chronic metabolic disorder characterized by insulin resistance and relative insulin deficiency. This condition has become a major public health concern worldwide, affecting millions of individuals and bearing significant morbidity and mortality. Understanding its history, diagnosis, treatment options, and prognosis is crucial for developing effective management strategies and improving patient outcomes.

Historical Overview

Type 2 diabetes was first distinguished as a separate clinical entity in the early 20th century. The term "diabetes mellitus" has roots dating back to ancient Egypt, where the disease was recognized by excessive urination. The modern understanding of diabetes began to take shape in the late 19th and early 20th centuries when researchers identified the role of insulin in glucose metabolism. Frederick Banting and Charles Best famously isolated insulin in 1921, marking a turning point in diabetes treatment. Since then, our understanding of type 2 diabetes has expanded from simple blood sugar control to complex metabolic interactions involving insulin resistance, obesity, and genetic factors.

Diagnosis of Type 2 Diabetes

The diagnosis of type 2 diabetes involves a combination of subjective symptoms and objective diagnostic tests. Patients often present with symptoms such as polyuria, polydipsia, unexplained weight loss, fatigue, blurred vision, and recurrent infections. Physical examination may reveal obesity, particularly central adiposity, and signs of complications like neuropathy or retinopathy. Laboratory tests are critical for confirmation. Fasting plasma glucose (FPG) levels ≥126 mg/dL on two occasions are diagnostic. An oral glucose tolerance test (OGTT) with a 2-hour plasma glucose ≥200 mg/dL is also indicative. Hemoglobin A1c levels ≥6.5% are used for diagnosis and reflect average blood glucose over the past two to three months. Additional diagnostic tools include lipid profiles, blood pressure measurements, and screening for microvascular and macrovascular complications.

Treatment Options

The management of type 2 diabetes involves lifestyle modifications and pharmacotherapy. Initial treatment emphasizes weight loss through diet and increased physical activity, which can significantly improve glycemic control. Pharmacologic interventions include oral agents such as metformin, sulfonylureas, DPP-4 inhibitors, SGLT2 inhibitors, and thiazolidinediones. Insulin therapy may be necessary for advanced cases or poorly controlled patients. Emerging therapies focus on novel mechanisms to enhance insulin sensitivity or secretion. Continuous glucose monitoring and patient education are vital components of successful management. Addressing associated cardiovascular risks—such as hypertension and dyslipidemia—is also crucial to reduce complications.

Prognosis and Future Outlook

The prognosis of type 2 diabetes largely depends on the effectiveness of management strategies and control of complications. With proper treatment, patients can lead relatively normal lives and avoid severe complications like nephropathy, retinopathy, neuropathy, and cardiovascular disease. However, poorly controlled diabetes increases the risk of life-threatening outcomes. Advances in technology, such as insulin pumps and real-time glucose monitoring, are improving disease management. Research is ongoing into gene therapy, novel pharmaceuticals, and personalized medicine to better prevent, diagnose, and treat this condition. Public health initiatives emphasizing prevention, early detection, and integrated care are expected to significantly reduce the burden of type 2 diabetes in the future.

References

  • American Diabetes Association. (2022). Standards of Medical Care in Diabetes—2022. Diabetes Care, 45(Supplement 1), S1–S232.
  • Chatterjee, S., Khunti, K., & Davies, M. J. (2017). Type 2 diabetes. The Lancet, 389(10085), 2239–2251.
  • DeFronzo, R. A. (2019). Pharmacologic therapy for type 2 diabetes mellitus. The Journal of Clinical Investigation, 129(8), 3198–3211.
  • Idris, I., & Donnelly, R. (2010). The epidemiology of type 2 diabetes. Indian Journal of Endocrinology and Metabolism, 14(3), 173–177.
  • Mohan, V., et al. (2009). Epidemiology of type 2 diabetes: ensure integration of prevention strategies. Journal of Diabetes, 1(1), 55–66.
  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). (2023). Diabetes Overview. https://www.niddk.nih.gov/health-information/diabetes
  • Peters, A. L., et al. (2017). Screening for type 2 diabetes: an update. The Journal of the American Medical Association, 317(20), 2101–2102.
  • Shaw, J. E., et al. (2018). Epidemiology of Diabetes and Its Complications. In Diabetes Care (pp. 1–20). Springer.
  • Tang, X., et al. (2020). Future directions in the management of type 2 diabetes. Diabetes Therapy, 11(10), 2331–2347.
  • World Health Organization. (2016). Global report on diabetes. WHO Press.

Related Assignments